Meta-Analysis of MS-Based Proteomics Studies Indicates Interferon Regulatory Factor 4 and Nucleobindin1 as Potential Prognostic and Drug Resistance Biomarkers in Diffuse Large B Cell Lymphoma

Meta-Analysis of MS-Based Proteomics Studies Indicates Interferon Regulatory Factor 4 and Nucleobindin1 as Potential Prognostic and Drug Resistance Biomarkers in Diffuse Large B Cell Lymphoma

The prognosis of diffuse large B cell lymphoma (DLBCL) is inaccurately predicted using clinical features and immunohistochemistry (IHC) algorithms. Nomination of a panel of molecules as the target for therapy and predicting prognosis in DLBCL is challenging because of the divergences in the results...

Full description

Bibliographic Details
Main Authors: Mostafa Ejtehadifar, Sara Zahedi, Paula Gameiro, José Cabeçadas, Maria Gomes da Silva, Hans C. Beck, Ana Sofia Carvalho, Rune Matthiesen
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Cells
Subjects:
annexinA5
diffuse large B cell lymphoma
germinal center
light zone
interferon regulatory factor 4
mass-spectrometry
Online Access:https://www.mdpi.com/2073-4409/12/1/196

Internet

https://www.mdpi.com/2073-4409/12/1/196

Similar Items